These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11556642)

  • 1. Oxcarbazepine in bipolar disorder.
    Teitelbaum M
    J Am Acad Child Adolesc Psychiatry; 2001 Sep; 40(9):993-4. PubMed ID: 11556642
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels.
    Stahl SM
    J Clin Psychiatry; 2004 Jun; 65(6):738-9. PubMed ID: 15291647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priapism associated with oxcarbazepine, aripiprazole, and lithium.
    Negin B; Murphy TK
    J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1223-4. PubMed ID: 16292111
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxcarbazepine (Trileptal) in the treatment of bipolar disorders: a review of efficacy and tolerability.
    Hellewell JS
    J Affect Disord; 2002 Dec; 72 Suppl 1():S23-34. PubMed ID: 12589900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of aggression in patients with bipolar disorder.
    Swann AC
    J Clin Psychiatry; 1999; 60 Suppl 15():25-8. PubMed ID: 10418811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxcarbazepine for mood disorders.
    Nasr S
    Am J Psychiatry; 2002 Oct; 159(10):1793. PubMed ID: 12359694
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxcarbazepine in the treatment of bipolar and schizoaffective disorders.
    Popova E; Leighton C; Bernabarre A; Bernardo M; Vieta E
    Expert Rev Neurother; 2007 Jun; 7(6):617-26. PubMed ID: 17563245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode.
    Benedetti A; Lattanzi L; Pini S; Musetti L; Dell'Osso L; Cassano GB
    J Affect Disord; 2004 Apr; 79(1-3):273-7. PubMed ID: 15023507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate in bipolar disorder: the Canadian perspective.
    Joffe RT
    Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S46-50. PubMed ID: 8098990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medications for aggressiveness in prison: focus on oxcarbazepine.
    Mattes JA
    J Am Acad Psychiatry Law; 2012; 40(2):234-8. PubMed ID: 22635296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxcarbazepine in a carbamazepine-intolerant patient with bipolar affective disorder: a case report.
    Kalra H; Dalal PK; Allet L; Janca A
    Psychiatr Danub; 2006 Jun; 18(1-2):90-1. PubMed ID: 16804505
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined antidepressant treatment: a risk factor for switching in bipolar patients.
    Gabbay V; O'Dowd MA; Asnis GM
    J Clin Psychiatry; 2002 Apr; 63(4):367; author reply 367-8. PubMed ID: 12000212
    [No Abstract]   [Full Text] [Related]  

  • 13. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder.
    Suppes T; Kelly DI; Hynan LS; Snow DE; Sureddi S; Foster B; Curley E
    Aust N Z J Psychiatry; 2007 May; 41(5):397-402. PubMed ID: 17464731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevention of relapse in bipolar disorder.
    Silverstone T; Romans S
    N Z Med J; 1995 Oct; 108(1009):397-8. PubMed ID: 7478331
    [No Abstract]   [Full Text] [Related]  

  • 16. The efficacy of atypical antipsychotics in bipolar disorders.
    Hirschfeld RM
    J Clin Psychiatry; 2003; 64 Suppl 8():15-21. PubMed ID: 12892537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.
    Hamrin V; McDonnell MA; Moffett J; Durso S
    Minerva Pediatr; 2008 Feb; 60(1):87-101. PubMed ID: 18277368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.
    Goodwin FK
    J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of bipolar disorder in older adults.
    Sajatovic M
    Int J Geriatr Psychiatry; 2002 Sep; 17(9):865-73. PubMed ID: 12221662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.